The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: terazosin hcl     Quarter: 2016Q3

Total Drug/Injury Combinations: 30     Number of Pages: 2

DRUGNAME PT EventCount
TERAZOSIN HCL Asthenia 2 view events
TERAZOSIN HCL Concomitant disease aggravated 2 view events
TERAZOSIN HCL Confusional state 2 view events
TERAZOSIN HCL Depression 2 view events
TERAZOSIN HCL Disturbance in attention 2 view events
TERAZOSIN HCL Energy increased 2 view events
TERAZOSIN HCL Epigastric discomfort 2 view events
TERAZOSIN HCL Feeling abnormal 2 view events
TERAZOSIN HCL Sneezing 2 view events
TERAZOSIN HCL Visual impairment 2 view events
TERAZOSIN HCL CAPSULES Blood pressure decreased 1 view events
TERAZOSIN HCL CAPSULES Cellulitis 1 view events
TERAZOSIN HCL CAPSULES Cough 1 view events
TERAZOSIN HCL CAPSULES Death 1 view events
TERAZOSIN HCL CAPSULES Dizziness 1 view events
TERAZOSIN HCL CAPSULES Dyspnoea 1 view events
TERAZOSIN HCL CAPSULES Eye irritation 1 view events
TERAZOSIN HCL CAPSULES Fall 1 view events
TERAZOSIN HCL CAPSULES Fluid retention 1 view events
TERAZOSIN HCL CAPSULES Head injury 1 view events

Total Drug/Injury Combinations: 30     Number of Pages: 2

NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)